Showing results (11-20 of 51) with videos related to
Sort By:
Pageof 6
Anticancer Research|December 31, 2021
High-purity Isolation for Genotyping Rare Cancer Cells from Blood Using a Microfluidic Chip Cell SorterMio Ikeda, Yasuhiro Koh, Jun Oyanagi, et al.Clinical Lung Cancer|May 29, 2021
Bloodborne Cytokines for Predicting Clinical Benefits and Immune-Related Adverse Events in Advanced Non-Small Cell Lung Cancer Treated With Anti-Programmed Cell Death 1 InhibitorsJun Oyanagi, Yasuhiro Koh, Koichi Sato, et al.Plos One|December 23, 2016
Characteristics and Prognostic Impact of Pneumonitis during Systemic Anti-Cancer Therapy in Patients with Advanced Non-Small-Cell Lung CancerDaichi Fujimoto, Ryoji Kato, Takeshi Morimoto, et al.Journal of Thoracic Disease|December 13, 2023
Adjacent angle size correlates with diagnostic sensitivity of endobronchial ultrasonography with a guide sheathMai Kato, Daichi Fujimoto, Takahiro Kaki, et al.JTO Clinical and Research Reports|September 30, 2021
Pembrolizumab Plus Amrubicin in Patients With Relapsed SCLC: Multi-Institutional, Single-Arm Phase 2 StudyHiroaki Akamatsu, Shunsuke Teraoka, Hidetoshi Hayashi, et al.Anticancer Research|October 28, 2015
Second-line Chemotherapy for Patients with Small Cell Lung Cancer and Interstitial Lung DiseaseDaichi Fujimoto, Ryoko Shimizu, Ryoji Kato, et al.Lung Cancer (Amsterdam, Netherlands)|May 18, 2019
Predictive value of serum protein levels in patients with advanced non-small cell lung cancer treated with nivolumabJun Oyanagi, Yasuhiro Koh, Koichi Sato, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 24, 2017
Early Immune-Related Adverse Events and Association with Outcome in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab: A Prospective Cohort StudyShunsuke Teraoka, Daichi Fujimoto, Takeshi Morimoto, et al.The European Respiratory Journal|October 18, 2014
Analysis of advanced lung cancer patients diagnosed following emergency admissionDaichi Fujimoto, Ryoko Shimizu, Takeshi Morimoto, et al.Cancers|June 2, 2021
Longitudinal Evaluation of PD-L1 Expression on Circulating Tumor Cells in Non-Small Cell Lung Cancer Patients Treated with NivolumabMio Ikeda, Yasuhiro Koh, Shunsuke Teraoka, et al.Pageof 6